Background
England's NHS Plan 2000 set out a clear agenda for the privatization of NHS services under the rubric of patient choice and in the absence of an evidence base. 1 Following on, 'Partnership for Care -Scotland's Health White Paper', February 2003 invoked spare capacity in the private sector as a means of treating patients whose waiting times exceeded the national guaranteed limit: nine months for inpatient treatment in 2003; 18 weeks from referral to treatment in 2011 and 12 weeks from agreeing to treatment to receiving treatment in 2012.
2-4 Once again no evidence was given in support of the policy of giving patients a choice of provider although fulfilling the terms of the European Union directive on cross-border healthcare and undue delay was a crucial element. 5 Within Scotland choice took the form of other territorial NHS Boards, the NHS Golden Jubilee National Hospital (GJNH) or the private sector with the intention that this would 'complement and not detract from NHS Boards' corporate responsibility to develop sustainable local solutions to long waits'. In June 2005, Andy Kerr, then Labour MSP and minister for health informed the Scottish Parliament that he and the National Waiting Times Unit (NHS) had held talks with 27 separate private healthcare providers in 2004 and 2005 about providing additional capacity and innovative solutions to reduce waiting times for elective surgery. 6, 7 In November 2006 the first block contract between the NHS and the private healthcare sector in Scotland was signed, prior to this England and Scotland had commissioned on a locally negotiated 'spot purchase' basis. 8 9 The annual contract value for orthopaedic surgery and outpatient appointments was £4.37 million, of which £3.75 million was for hip and knee replacements with the rest classed as minor orthopaedics. 10 For Scotland as a whole over £373 million was spent on orthopaedics services in 2008/09, around 4% of all NHS spending; however, the split between public and private treatment is not collected centrally.
11
The use of the private sector to deliver elective treatments to NHS funded patients in Scotland has been controversial due to poor value for money. In January 2010, the Scottish Government terminated the ISTC contract (Scotland's only ISTC contract to date) when academic analysis revealed a £1.6 million gap (62% of total cash paid) between what had been paid and what had been delivered in treatments to NHS patients in the first 13 months of operation. 12 Current Scottish government policy is to 'effectively eliminate use of the private sector for planned care' although recent figures show NHS Scotland spent £35.8 million on 12 800 patient referrals to private hospitals in financial year 2013/14 compared to £22.8 million for 2239 referrals in 2011/12.
13,14
The UK wide Equality Act 2010 introduced a public sector equality duty requiring public bodies to pay due regard to reducing inequalities related to socio-economic status, age and sex. 15 NHS Scotland advocates impact assessments to ensure that NHS Boards and other health bodies meet the requirements of the public sector equality duty when developing and delivering policies, practices and services. 16 Inequalities and inequities in elective hip arthroplasty rates are well documented in England by sex, age and socioeconomic deprivation. [17] [18] [19] [20] [21] [22] [23] [24] Women, older patients and those living in the most deprived areas receive fewer treatments relative to need. 17, 18, 23, 24 Inequalities in treatment rates also exist in Scotland. 25 No change in socio-economic equity in hip replacement treatment was found between 2001 and 2008 during the period of increasing patient choice and use of private hospitals for elective care in England. 26 There has been no study of the impact of patient choice in Scotland on inequalities in treatment. Hip arthroplasty is a high volume procedure with a relatively long length of stay in hospital and is a good choice of procedure to test inequality. 26 The aims of this study are: Denominators: Census estimates mid-year Scotland populations for the first part of the financial year, for example the mid-year population for 1993 was used for financial year 1993/94 and so on.
Analysis
Elective and Emergency Treatment Rates Numbers and rates of elective and emergency hip arthroplasties were calculated by financial year (01 April to 31 March the following year) for all Scotland from 01 April 1993 to 31 March 2013 with 95% confidence intervals, directly standardized by age to the European Standard Population 2013. 28 Numbers and age standardized elective hip arthroplasty rates were also calculated separately by provider type.
Trends by provider type
The number of treatments commissioned by each territorial NHS Board from either the NHS (a patient's own NHS Board, another territorial NHS Board or the GJNH) or the private sector was calculated by financial year along with numbers of treatments provided in-area (i.e. Poisson regression models were built using forward selection in Stata version 12.1 to calculate adjusted incidence rate ratios (IRRs) on the total number of elective hip arthroplasties with covariates sex, age, SIMD and provider type offset by the total midyear Scotland population years for the time period involved. Interactions were tested between provider type and the other three covariates and where interactions existed, models were built using dummy variables to estimate the effect of the interactions. Operation rates by age group and SIMD quintile were plotted against financial year of operation and the proportionate increase in 2012/13 compared to 2002/03 was calculated for each category.
Results

Trends in treatment rates
There The recovery in elective treatment rate in 2008/09 was the result of private sector activity rather than territorial NHS 
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Board activity (see Fig. 2 and Table A in Supplementary materials). The treatment rate for the territorial NHS Boards had not recovered to 2006/07 levels by 2011/12 or 2012/13 although the overall national rate recovered due to the additional capacity provided by the GJNH, a health board in its own right. In-area treatment rates were lower for Fife, Grampian, Highland and Lothian NHS Boards in 2011/12 and 2012/13 than 2006/07 (see Table B in Supplementary materials).
There was a −3.2%, −0.9% and 2.4% change in the number of treatments commissioned by territorial NHS Boards from the NHS in 2007/08, 2008/09 and 2009/10 respectively compared to 2006/07 (see Table C in Supplementary materials). Over the same time periods there was a −4.2%, −5.8% and −3.1% change in the number of treatments provided in-area by NHS Boards and a 13.5%, 248% and 181% change in the number of treatments commissioned from the private sector (see Tables C & D The covariates sex, age, SIMD and provider type were all found to be significant predictors in the Poisson model on number of operations (P < 0.0001 for all). A significant interaction with provider type was found for age and SIMD (P < 0.0001 for both) but not for sex (P = 0.1661). There are clear differences in the patterns of inequality by both age group and by SIMD quintile for the GJNH and private providers, both compared to territorial NHS Boards (see Table 1 
and Figures A & B in Supplementary materials).
There were differences in the proportionate increase in treatment rates by age group from 2002/03 to 2012/13 across all provider types: patients aged 75-79 years increased their treatment rate by 65.7%; those aged 85 years and over increased their treatment rate by 31.3% (see Fig. 3 ). Over the same time period, the two least deprived quintiles SIMD 4 and 5 increased their treatment rates by 67.3% and 85.4% respectively while the two most deprived quintiles SIMD 1 and 2 increased their treatment rates by 47.7% and 49.5% respectively (see Figure C in Supplementary materials). 
Discussion
Main finding of the study
The claim made by NHS Scotland's 2003 white paper that the additional use of the private sector would provide 'sustainable local solutions to long waits' is not supported by the evidence. On the contrary, local provision by NHS Boards decreased and although median waiting times for elective hip replacement in Scotland fell from 156 days in 2005/06 to 78 days in 2009/10, the only increase in NHS capacity was at the GJNH. 29 Those NHS Boards with the greatest use of the private sector for elective surgery experienced the largest reductions in direct NHS provision and of those Fife, Grampian and Lothian NHS Boards had not recovered 2006/07 levels of in-area provision by 2012/13. Inequality in treatment rates has increased since 2002 with patients aged 85 years and over and those living in the more socio-economically deprived areas of Scotland significantly disadvantaged.
What is already known on this topic
Provision This is the first study to look at the impact of diverting NHS funds to the private sector on direct and in-area NHS provision. It confirms the conclusions of the 2006 House of Commons Health Select Committee (HSC) that in the English NHS, the private sector in the form of ISTCs 'had not made a major direct contribution to increasing capacity'. 30 Bernard Ribeiro, then president of the Royal College of Surgeons of England informed the committee that ISTCs were leaving 'NHS facilities under-utilized with a concurrent deleterious effect on fragile NHS Trust financial balances'. 31 In addition, ISTCs were being paid on referrals, not treatments, and consequently an estimated £252 million (14.8%) of the initial £1.7 bn paid to the private sector under the English ISTC programme from 2003 to 2010 was for treatments and diagnostic procedures never carried out. 32 Business cases and contracts for English ISTCs have been withheld or redacted by the Department of Health on grounds of commercial confidentiality making independent scrutiny, even by the HSC, impossible and as private sector organizations performing public functions, ISTCs are not subject to the Freedom of Information Act 2000. [33] [34] [35] Consequently around 5 billion pounds paid by the NHS to the private healthcare sector has remained essentially unaudited. The HSC recommended the National Audit Office (NAO) to carry out an investigation into ISTCs, and whether they increased productivity in the NHS; no such investigation has been undertaken by the NAO. 30, 36 Most privately provided NHS funded primary hip replacements in England, Wales and Northern Ireland, however, are actually delivered by non-ISTC private Table 1 Number of treatments (N) and incidence rate ratios (IRR) with 95% confidence intervals for interactions between age # provider and Scottish 37 Neither has there been any scrutiny of the larger program of NHS funded patients treated privately outside of the ISTC program.
NHS England provided the blueprint for the Scottish Regional Treatment Centre, Scotland's only ISTC. 38 England's health secretary John Reid made 'evangelical' trips to Scotland to extoll the virtues of the private sector when the Scottish executive were engaged in discussions with private healthcare companies including Alliance Medical, Capio Healthcare (now part of Ramsey Health Care), Care UK, Nations Healthcare Ltd (now part of Circle), UK Specialist Hospitals (now part of Care UK) and Netcare, some of the main players in wave one of the English ISTC programme. 7, 39 In Scotland, Netcare operated a similar contract regime to that in England with the referring NHS Boards (mainly Fife, Grampian and Tayside) guaranteeing payment for each patient referred (whether treated or not) to at least 90% of the agreed minimum referral value of the contract; this 'Take or Pay' figure was 100% in English ISTCs. 38 Overpayment to ISTC providers has been found in England and Scotland.
12,32 It is not known how contracts with non-ISTC private providers operate.
Inequality
The impact of ISTC private sector provision of NHS funded treatments on inequality in England shows a bias towards patients from less deprived areas but no clear evidence of any sex or age bias. [40] [41] [42] The exclusion criterion for English ISTCs of 'lack of necessary social support, e.g. no carer/escort available at discharge', the main predictor of delay in discharge, may work against older people and those with higher levels of deprivation who typically have longer lengths of stay in hospital following surgery. 8, 43, 44 There are no substantial differences in the medical exclusion criteria used by the Scottish ISTC to those practised in the NHS. 10, 45 Additionally, patients in receipt of directly provided NHS hip replacements have worse symptoms, more comorbidities and poorer outcomes than ISTC patients. 41, 42 What this study adds
Research from England has shown people living in the most deprived areas receive 70% fewer hip replacements than needed and those aged 85 and over 30% less. 17 The findings of increasing inequalities in relation to age and deprivation in Scotland warrant further investigation including the effects of reductions in territorial NHS Board direct and inarea provision, use of the private sector and use of the GJNH as an alternative to local hospital treatment. The patterns of inequality by socio-economic deprivation for territorial NHS Boards and the GJNH are similar to those found for publicly funded hip replacements in England and also in Denmark and Spain; however, the private sector in Scotland appears to treat a disproportionately high number of NHS funded patients from the least deprived quintiles of the population. 
Limitations of the study
The destination of a patient will depend not only on their individual choice of provider but also on the range of choices made available to them, normally by their GP, and whether the patient is accepted or rejected by the provider chosen. It would be extremely helpful to understand these mechanisms both quantitatively and qualitatively and their role in influencing inequality.
NHS funded patients treated outside of Scotland are not included in this study.
Conclusion
Patient choice and use of private sector in Scotland was associated with a decrease in direct and in-area NHS provision and may have contributed to an increase in age-related and socio-economic inequalities. By 2012/13 territorial NHS Boards had not recovered 2006/07 levels of provision; this was most marked for four NHS Boards, three of which had the greatest use of the private sector, namely Fife, Grampian and Lothian. The expansion of the GJNH did provide additional overall capacity and may have lessened socio-economic inequalities; however, it may have increased age-related inequalities in treatment as the GJNH attracts younger patients.
Equality impact assessments should consider the role of the private sector in increasing inequalities by age and deprivation and on locally sustainable solutions. Reductions in waiting times and waiting time targets are blunt instruments for understanding the effect of using the private sector on public provision and overall capacity.
Supplementary data
Supplementary data are available at the Journal of Public Health online.
